Your browser doesn't support javascript.
loading
Renin-Angiotensin System Pathway Therapeutics Associated With Improved Outcomes in Males Hospitalized With COVID-19.
Rocheleau, Genevieve L Y; Lee, Terry; Mohammed, Yassene; Goodlett, David; Burns, Kevin; Cheng, Matthew P; Tran, Karen; Sweet, David; Marshall, John; Slutsky, Arthur S; Murthy, Srinivas; Singer, Joel; Patrick, David M; Du, Bin; Peng, Zhiyong; Lee, Todd C; Boyd, John H; Walley, Keith R; Lamontagne, Francois; Fowler, Robert; Winston, Brent W; Haljan, Greg; Vinh, Donald C; McGeer, Alison; Maslove, David; Patrigeon, Santiago Perez; Mann, Puneet; Donohoe, Kathryn; Hernandez, Geraldine; Russell, James A.
Afiliación
  • Rocheleau GLY; Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
  • Lee T; Centre for Health Evaluation and Outcome Science (CHEOS), St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
  • Mohammed Y; University of Victoria, Genome BC Proteomics Centre, Victoria, BC, Canada.
  • Goodlett D; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
  • Burns K; University of Victoria, Genome BC Proteomics Centre, Victoria, BC, Canada.
  • Cheng MP; Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, Canada.
  • Tran K; International Centre for Cancer Vaccine Science, University of Gdansk, Gdansk, Poland.
  • Sweet D; Division of Nephrology, Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
  • Marshall J; Divisions of Infectious Diseases & Medical Microbiology, McGill University Health Center, McGill's Interdisciplinary Initiative in Infection and Immunity, Montreal, QC, Canada.
  • Slutsky AS; Division of General Internal Medicine, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada.
  • Murthy S; Division of Critical Care Medicine, Vancouver General Hospital, Vancouver, BC, Canada.
  • Singer J; Department of Surgery, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Patrick DM; Department of Surgery, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Du B; British Columbia Children's Hospital, University of British Columbia, Vancouver, BC, Canada.
  • Peng Z; Centre for Health Evaluation and Outcome Science (CHEOS), St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
  • Lee TC; British Columbia Centre for Disease Control (BCCDC), and School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
  • Boyd JH; Medical ICU, Peking Union Medical College Hospital, Beijing, China.
  • Walley KR; Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
  • Lamontagne F; Divisions of Infectious Diseases & Medical Microbiology, McGill University Health Center, McGill's Interdisciplinary Initiative in Infection and Immunity, Montreal, QC, Canada.
  • Fowler R; Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
  • Winston BW; Division of Critical Care Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
  • Haljan G; Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
  • Vinh DC; Division of Critical Care Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
  • McGeer A; University of Sherbrooke, Sherbrooke, QC, Canada.
  • Maslove D; Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Patrigeon SP; Departments of Critical Care Medicine, Medicine and Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada.
  • Mann P; Department of Medicine, Surrey Memorial Hospital, Surrey, BC, Canada.
  • Donohoe K; Divisions of Infectious Diseases & Medical Microbiology, McGill University Health Center, McGill's Interdisciplinary Initiative in Infection and Immunity, Montreal, QC, Canada.
  • Hernandez G; Mt. Sinai Hospital and University of Toronto, Toronto, ON, Canada.
  • Russell JA; Department of Medicine, Kingston General Hospital and Queen's University, Kingston, ON, Canada.
Crit Care Med ; 50(9): 1306-1317, 2022 09 01.
Article en En | MEDLINE | ID: mdl-35607951

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Hipertensión Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Crit Care Med Año: 2022 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Hipertensión Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Crit Care Med Año: 2022 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos